Advertisement
Advertisement
U.S. markets open in 3 hours 37 minutes
S&P Futures
4,134.50 +10.00 (+0.24%) Dow Futures
32,793.00 +56.00 (+0.17%) Nasdaq Futures
13,078.00 +46.50 (+0.36%) Russell 2000 Futures
1,918.00 +3.40 (+0.18%) Crude Oil
89.85 -0.65 (-0.72%) Gold
1,809.40 -2.90 (-0.16%)
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 11.03 |
| Open | 10.83 |
| Bid | 10.95 x 28000 |
| Ask | 10.96 x 3100 |
| Day's Range | 10.82 - 11.15 |
| 52 Week Range | 6.78 - 11.15 |
| Volume | |
| Avg. Volume | 13,277,177 |
| Market Cap | 12.216B |
| Beta (5Y Monthly) | 1.31 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.56 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Nov 27, 2017 |
| 1y Target Est | 10.73 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
3% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for TEVA
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Teva Pharmaceutical IndustriesAnalyst Report: Teva Phar Inds LtTeva Pharmaceutical Industries Ltd. is the world's largest generic pharmaceutical manufacturer, with roughly 76 billion tablets and capsules produced annually. The company has over 37,000 employees and a presence in 60 countries. One of every 10 prescriptions in the U.S. is filled with Teva products.RatingFair ValueEconomic Moat26 days agoArgus Research
- Motley Fool
Why Teva Stock Trounced the Market on Friday
The stock of Teva Pharmaceutical Industries (NYSE: TEVA) closed out the trading week in style, popping by almost 6% on Friday. The generic-drug specialist was the subject of a recommendation upgrade from a noted financial institution, hence the share price rise. Analyst Jason Gerberry from the bank's securities unit raised his recommendation on Teva from neutral to buy.
- Motley Fool
Is This Rare Berkshire Hathaway Miscue Finally a Buy?
Berkshire Hathaway cut bait with the struggling drugmaker Teva Pharmaceutical Industries in late 2021.
- Barrons.com
AbbVie Stock Slips After Earnings, Charge for Potential Opioid Deal
Management confirmed financial forecasts it had issued earlier. The drug company's second-quarter results were roughly in line with expectations.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
